Sfoglia per Autore
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study
2003-01-01 Calabresi, P; Marti, M; Picconi, B; Saulle, E; Costa, C; Centonze, D; Pisani, F; Bernardi, G
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism
2003-01-01 Maccarrone, M; Gubellini, P; Bari, M; Picconi, B; Battista, N; Centonze, D; Bernardi, G; Finazzi-Agrò, A; Calabresi, P.
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
2003-01-01 Picconi, B; Centonze, D; Håkansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, Ma; Calabresi, P
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease.
2004-01-01 Saulle, E; Gubellini, P; Picconi, B; Centonze, D; Tropepi, D; Pisani, A; Morari, M; Marti, M; Rossi, L; Papa, M; Bernardi, G; Calabresi, P.
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors
2004-01-01 Centonze, D; Usiello, A; Costa, C; Picconi, B; Erbs, E; Bernardi, G; Borrelli, E; Calabresi, P
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism.
2004-01-01 Picconi, B; Centonze, D; Rossi, S; Bernardi, G; Calabresi, P
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.
2004-01-01 Picconi, B; Gardoni, F; Centonze, D; Mauceri, D; Cenci, Ma; Bernardi, G; Calabresi, P; Di Luca, M; Ghiglieri, Veronica
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
2004-01-01 Lundblad, M; Picconi, B; Lindgren, H; Cenci, Ma
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism
2005-01-01 Centonze, D; Gubellini, P; Rossi, S; Picconi, B; Pisani, A; Bernardi, G; Calabresi, P; Baunez, C
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease
2005-01-01 Picconi, B; Pisani, A; Barone, I; Bonsi, P; Centonze, D; Bernardi, G; Calabresi, P
Deficits of glutamate transmission in the striatum of experimental hemiballism.
2006-01-01 Centonze, D; Rossi, S; Gubellini, P; De Chiara, V; Tscherter, A; Prosperetti, C; Picconi, B; Bernardi, G; Calabresi, P; Baunez, C
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease.
2006-01-01 Rossi, S; Prosperetti, C; Picconi, B; De Chiara, V; Mataluni, G; Bernardi, G; Calabresi, P; Centonze, D
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases
2006-01-01 Napolitano, M; Picconi, B; Centonze, D; Bernardi, G; Calabresi, P; Gulino, A
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum.
2006-01-01 Centonze, D; Prosperetti, C; Barone, I; Rossi, S; Picconi, B; Tscherter, A; De Chiara, V; Bernardi, G; Calabresi, P
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition.
2006-01-01 Di Filippo, M; Picconi, B; Costa, C; Bagetta, V; Tantucci, M; Parnetti, L; Calabresi, P
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia
2006-01-01 Costa, C; Martella, G; Picconi, B; Prosperetti, C; Pisani, A; Di Filippo, M; Pisani, F; Bernardi, G; Calabresi, P
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.
2006-01-01 Calabresi, P; Picconi, B; Parnetti, L; Di Filippo, M
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity
2006-01-01 Picconi, B; Bagetta, V; Paille, V; Ghiglieri, V; Barone, I; Bernardi, G; Calabresi, P
NR2B subunit exerts a critical role in postischemic synaptic plasticity.
2006-01-01 Picconi, B; Tortiglione, A; Barone, I; Centonze, D; Gardoni, F; Gubellini, P; Bonsi, P; Pisani, A; Bernardi, G; Di Luca, M; Calabresi, P
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine
2006-01-01 Picconi, B; Barone, I; Pisani, A; Nicolai, R; Benatti, P; Bernardi, G; Calvani, M; Calabresi, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study | 1-gen-2003 | Calabresi, P; Marti, M; Picconi, B; Saulle, E; Costa, C; Centonze, D; Pisani, F; Bernardi, G | |
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism | 1-gen-2003 | Maccarrone, M; Gubellini, P; Bari, M; Picconi, B; Battista, N; Centonze, D; Bernardi, G; Finazzi-Agrò, A; Calabresi, P. | |
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | 1-gen-2003 | Picconi, B; Centonze, D; Håkansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, Ma; Calabresi, P | |
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. | 1-gen-2004 | Saulle, E; Gubellini, P; Picconi, B; Centonze, D; Tropepi, D; Pisani, A; Morari, M; Marti, M; Rossi, L; Papa, M; Bernardi, G; Calabresi, P. | |
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors | 1-gen-2004 | Centonze, D; Usiello, A; Costa, C; Picconi, B; Erbs, E; Bernardi, G; Borrelli, E; Calabresi, P | |
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. | 1-gen-2004 | Picconi, B; Centonze, D; Rossi, S; Bernardi, G; Calabresi, P | |
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. | 1-gen-2004 | Picconi, B; Gardoni, F; Centonze, D; Mauceri, D; Cenci, Ma; Bernardi, G; Calabresi, P; Di Luca, M; Ghiglieri, Veronica | |
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. | 1-gen-2004 | Lundblad, M; Picconi, B; Lindgren, H; Cenci, Ma | |
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism | 1-gen-2005 | Centonze, D; Gubellini, P; Rossi, S; Picconi, B; Pisani, A; Bernardi, G; Calabresi, P; Baunez, C | |
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease | 1-gen-2005 | Picconi, B; Pisani, A; Barone, I; Bonsi, P; Centonze, D; Bernardi, G; Calabresi, P | |
Deficits of glutamate transmission in the striatum of experimental hemiballism. | 1-gen-2006 | Centonze, D; Rossi, S; Gubellini, P; De Chiara, V; Tscherter, A; Prosperetti, C; Picconi, B; Bernardi, G; Calabresi, P; Baunez, C | |
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. | 1-gen-2006 | Rossi, S; Prosperetti, C; Picconi, B; De Chiara, V; Mataluni, G; Bernardi, G; Calabresi, P; Centonze, D | |
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases | 1-gen-2006 | Napolitano, M; Picconi, B; Centonze, D; Bernardi, G; Calabresi, P; Gulino, A | |
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. | 1-gen-2006 | Centonze, D; Prosperetti, C; Barone, I; Rossi, S; Picconi, B; Tscherter, A; De Chiara, V; Bernardi, G; Calabresi, P | |
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. | 1-gen-2006 | Di Filippo, M; Picconi, B; Costa, C; Bagetta, V; Tantucci, M; Parnetti, L; Calabresi, P | |
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia | 1-gen-2006 | Costa, C; Martella, G; Picconi, B; Prosperetti, C; Pisani, A; Di Filippo, M; Pisani, F; Bernardi, G; Calabresi, P | |
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. | 1-gen-2006 | Calabresi, P; Picconi, B; Parnetti, L; Di Filippo, M | |
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity | 1-gen-2006 | Picconi, B; Bagetta, V; Paille, V; Ghiglieri, V; Barone, I; Bernardi, G; Calabresi, P | |
NR2B subunit exerts a critical role in postischemic synaptic plasticity. | 1-gen-2006 | Picconi, B; Tortiglione, A; Barone, I; Centonze, D; Gardoni, F; Gubellini, P; Bonsi, P; Pisani, A; Bernardi, G; Di Luca, M; Calabresi, P | |
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine | 1-gen-2006 | Picconi, B; Barone, I; Pisani, A; Nicolai, R; Benatti, P; Bernardi, G; Calvani, M; Calabresi, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile